PAAMCP
AMPH icon

Pacific Alternative Asset Management Company (PAAMCO)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Pacific Alternative Asset Management Company (PAAMCO)’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-74,048
Closed -$863K – 106
2014
Q3 		$863K Buy
+74,048
New +$771K 0.1% 154

Other funds holding AMPH

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pacific Alternative Asset Management Company (PAAMCO)'s AMPH Position: Q4 2014 in Review

Pacific Alternative Asset Management Company (PAAMCO) sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2014, closing a stake of 74,048 shares — an estimated $863K sold.

Pacific Alternative Asset Management Company (PAAMCO) first reported a position in AMPH in Q3 2014 and held it in 1 quarter. The position peaked at $863K in Q3 2014. 55 funds tracked by Wall St. Rank hold AMPH as of Q4 2014.

  • Pacific Alternative Asset Management Company (PAAMCO) reported no remaining Amphastar Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Pacific Alternative Asset Management Company (PAAMCO) sold 74,048 Amphastar Pharmaceuticals shares in Q4 2014, an estimated $863K.
  • Pacific Alternative Asset Management Company (PAAMCO) first reported a position in Amphastar Pharmaceuticals in Q3 2014 and held it in 1 quarter.
  • Pacific Alternative Asset Management Company (PAAMCO)'s Amphastar Pharmaceuticals position peaked at $863K in Q3 2014.
  • 55 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2014.

Based on Pacific Alternative Asset Management Company (PAAMCO)'s 13F filing for Q4 2014, filed 13 Feb 2015.